10-Q: Centene Reports Mixed Q3 Results Amid Medicaid Redeterminations and Medicare Changes

Centene Corporation's third-quarter results show revenue growth offset by increased medical costs and impacts from Medicaid redeterminations and Medicare Star ratings.

Summary

• Centene Corporation reported a 10% increase in total revenues to $42.0 billion for the third quarter of 2024, compared to the same period in 2023.
• Premium and service revenues grew by 6% year-over-year to $36.9 billion.
• The health benefits ratio (HBR) increased to 89.2% from 87.0% in the third quarter of 2023, primarily due to higher acuity in Medicaid and Medicare Star rating impacts.
• Selling, general, and administrative (SG&A) expenses decreased to 8.3% of premium and service revenues, compared to 8.7% in the prior year.
• Adjusted diluted earnings per share (EPS) were $1.62, down from $2.00 in the third quarter of 2023.
• The company's managed care membership increased by 2% year-over-year to 28.6 million members.
• Medicaid membership declined due to redeterminations, while Marketplace membership grew by 22%.

Sentiment

Score: 5

Explanation: The document presents a mixed picture with positive revenue growth but challenges in profitability and membership in key segments. The increase in HBR and decrease in adjusted EPS are concerning, while the growth in Marketplace and PDP membership is encouraging. The overall sentiment is neutral to slightly negative.

Positives

• Total revenues saw a solid 10% increase year-over-year.
• The company experienced a 22% increase in Marketplace membership.
• Medicare PDP membership grew by 49% year-over-year.
• The SG&A expense ratio improved to 8.3% from 8.7% in the prior year.
• The company continues to repurchase shares, demonstrating confidence in its value.

Negatives

• The health benefits ratio (HBR) increased to 89.2%, indicating higher medical costs.
• Adjusted diluted EPS decreased to $1.62 from $2.00 in the third quarter of 2023.
• Medicaid membership declined due to redeterminations.
• Medicare Advantage membership declined 14% year-over-year.
• Operating cash flows used cash of $1.0 billion in the third quarter of 2024.

Risks

• Medicaid redeterminations continue to impact membership and may lead to further declines.
• The company's Medicare Star quality ratings have decreased, impacting revenue.
• The company faces potential challenges in matching rates to acuity post-redeterminations.
• There are ongoing regulatory uncertainties and potential changes in healthcare policies.
• The company is subject to legal and regulatory proceedings in the normal course of business.

Future Outlook

The company expects continued growth in the Marketplace business and is working to address challenges in Medicaid and Medicare. They anticipate a premium deficiency reserve in the fourth quarter of 2024 due to Medicare Star ratings. They also expect to spend approximately $170 million in additional capital expenditures.

Management Comments

• The company is focused on delivering access to high-quality, affordable healthcare.
• They believe they are well-positioned to meet the needs of the changing healthcare landscape.
• The company is actively engaged to help ensure individuals take the state agency requested action to confirm eligibility in their Medicaid coverage or find other appropriate coverage.
• They are working with state partners to match rates to acuity post-redeterminations.
• The company is targeting initiatives to improve productivity, efficiencies and reduced organizational costs.

Industry Context

The report reflects the ongoing challenges in the healthcare industry, including Medicaid redeterminations, changes in Medicare Star ratings, and the competitive landscape of the Health Insurance Marketplace. The company's performance is influenced by government policies and regulatory changes, as well as the need to manage medical costs effectively.

Comparison to Industry Standards

• Centene's HBR of 89.2% is higher than some of its peers, indicating higher medical costs relative to premium revenue. For example, UnitedHealth Group reported a medical care ratio of 82.9% in their Q3 2024 results.
• The company's adjusted SG&A expense ratio of 8.3% is competitive with other large managed care organizations. Humana reported an operating expense ratio of 11.8% in their Q3 2024 results.
• Centene's 22% growth in Marketplace membership is a positive sign, reflecting strong product positioning and market growth, which is comparable to other insurers with a strong presence in the ACA marketplace.
• The decline in Medicare Advantage membership and the impact of lower Star ratings are challenges faced by other insurers in the sector, such as CVS Health (Aetna) and Humana, who have also reported similar issues.
• The company's share repurchase program is a common practice among large healthcare companies, reflecting a focus on shareholder value.

Legal Proceedings

• The company is routinely subjected to legal and regulatory proceedings in the normal course of business.
• These matters can include compliance reviews, investigations, litigation, and disputes regarding various aspects of their operations.
• The company intends to vigorously defend itself against legal and regulatory proceedings.

Stakeholder Impact

• Shareholders may be concerned about the decrease in adjusted EPS and the increase in HBR.
• Employees may be affected by restructuring and cost-saving initiatives.
• Members may experience changes in coverage due to Medicaid redeterminations and Medicare plan changes.
• Providers may be impacted by changes in reimbursement rates and network participation.
• Customers may see changes in product offerings and service delivery.

Next Steps

• The company will continue to work with state partners to match rates to acuity post-redeterminations.
• They will focus on improving Medicare Star ratings.
• The company will expand its Marketplace product into new counties and states.
• They will implement a new third-party pharmacy benefits management (PBM) contract.
• The company will continue to target initiatives to improve productivity, efficiencies and reduced organizational costs.

Key Dates

Keywords

Medicaid, Medicare, Marketplace, Health Benefits Ratio, HBR, Membership, Redeterminations, Star Ratings, Revenue, Earnings Per Share, EPS, SG&A, Healthcare, Managed Care